NPPA computed the Retail Price of Empagliflozin 5 mg + Metformin Hydrochloride IP 500 mg for M/s Skymap Pharmaceuticals Pvt. Ltd. (Manufacturer) & M/s Glensmith Labs Pvt. Ltd. (Marketer)

Mar 10, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on March 06, 2025, issued the Computation of Retail Price of Empagliflozin 5 mg + Metformin Hydrochloride IP 500 mg for M/s Skymap Pharmaceuticals Pvt. Ltd. (Manufacturer) & M/s Glensmith Labs Pvt. Ltd. (Marketer)

The following has been stated namely: -

• The Retail Price has been computed based on the data from June, 2024

• The Retail Price has been computed for Each Film Coated Tablet Containing Empagliflozin 5 mg + Metformin Hydrochloride IP 500 mg for M/s Skymap Pharmaceuticals Pvt. Ltd. (Manufacturer) & M/s Glensmith Labs Pvt. Ltd. (Marketer)

• The Total MAT is 3,61,57,496


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT